Opioid Dosages Flashcards
Morphine (alternate name):
Duramorph
Morphine structure:
Phenathrene derivative of opium
Morphine MOA:
- Mu, Kappa, Delta agonist
- Inhibit (GPCR -Gi) release of excitatory neurotransmitters Ach, NE, Dopamine, Substance P at presynaptic neurons (pre-synaptic Ca channel inactivation)
- Increase post-synaptic K conductance (hyperpolarizes)
- Inhibits adenylate cyclase by activating GI proteins and subsequently reduces cAMP, decreasing neuronal excitability
- Upregulation of adenylate cyclase can lead to withdrawal symptoms if drug/inhibition is removed (chronic use)
Morphine Onset:
15 min
Morphine Duration of action:
2-4 h
Morphine PB:
30%
Morphine metabolism:
Hepatic (glucuronidation)
Renal excretion
Morphine IV dose:
0.05-0.3 mg/kg
(usually 0.1 mg/kg)
Morphine side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Morphine Contradindications / Cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- S - Serotonin syndrome (with MAOI, don’t give if MAOI taken within 14 days)
- S - Sphincter of Odds spasm (consider biliary disease or acute pancreatitis)
- H - Histamine Release
- P - Pruritus (itching)
Meperidine (alternate name):
Demerol
Meperidine structure:
Phenylpiperidine
Meperidine potency:
0.1x morphine potency
Meperidine MOA:
- Mu, Kappa, Delta agonist
- Inhibit (GPCR -Gi) release of excitatory neurotransmitters Ach, NE, Dopamine, Substance P at presynaptic neurons (pre-synaptic Ca channel inactivation)
- Increase post-synaptic K conductance (hyperpolarizes)
- Inhibits adenylate cyclase by activating GI proteins and subsequently reduces cAMP, decreasing neuronal excitability
- Upregulation of adenylate cyclase can lead to withdrawal symptoms if drug/inhibition is removed (chronic use)
Meperidine Onset:
5 min
Meperidine Duration of action:
2-4 h
Meperidine Protein Binding:
75%
Meperidine metabolism:
CYP3A4 (demethylation) to normeperidine,
Renally excreted
Meperidine IV dose:
IV: 25-100 mg
IV: 50mg Q 3-4 hr for pain or shivering
Meperidine side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Meperidine Contraindications / Cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- S - Serotonin syndrome (with MAOI, don’t give if MAOI taken within 14 days)
- S - Sphincter of Odds spasm (consider biliary disease or acute pancreatitis)
- H - Histamine Release
- P - Pruritus (itching)
Methadone (alternate name):
dolophine
Methadone structure:
Synthetic opioid agonist
Racemic mixture
Methadone MOA:
- Mu agonist
- Inhibit (GPCR -Gi) the release of excitatory neurotransmitters Ach, NE, dopamine, glutamate, and substance P (pre-synaptic Ca channel inactivation)
- Increase post-synaptic K conductance (hyperpolarizes)
- NMDA antagonist – inhibits serotonin and NE uptake
- Inhibits adenylate cyclase by activating GI proteins and subsequently reduces cAMP, decreasing neuronal excitability
- Upregulation of adenylate cyclase can lead to withdrawal symptoms if drug/inhibition is removed (chronic use)
Methadone Onset:
15 min
Methadone Duration of action:
4-6 hr
Methadone PB:
95%
Methadone elimination half time:
24 hr
Methadone Metabolism:
CYP3A4, 2B6
really excreted
Methadone IV dose:
2.5-10 mg Q24hr
Methadone side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Methadone Contraindications / cautions
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- S - Serotonin syndrome (with MAOI, don’t give if MAOI taken within 14 days)
- S - Sphincter of Odds spasm (consider biliary disease or acute pancreatitis)
- H - Histamine Release
- P - Pruritus (itching)
*8. QT Prolongation
Hydromorphone (alternate name)
Dilaudid
Hydromorphone structure:
morphone derivative
Hydromorphone potency:
10x as strong as morphine
Hydromorphone MOA:
- Mu agonist
- Inhibit (GPCR -Gi) the release of excitatory neurotransmitters Ach, NE, dopamine, glutamate, and substance P (pre-synaptic Ca channel inactivation)
- Increase post-synaptic K conductance (hyperpolarizes)
- Inhibits adenylate cyclase by activating GI proteins and subsequently reduces cAMP, decreasing neuronal excitability
- Upregulation of adenylate cyclase can lead to withdrawal symptoms if drug/inhibition is removed (chronic use)
Hydromorphone Onset:
15 min
Hydromorphone Duration of action:
2-4 hr
Hydromorphone PB:
30%
Hydromorphone metabolism:
by liver (glucuronidation) into inactive metabolites and excreted by kidney and bile
Hydromorphone IV intra-op dose:
IV: 0.01-0.02 mg/kg intra-op
Hydromorphone IV post-op pain dose:
IV: 0.1-0.25 mg Q 10-15 min post-op
Hydromorphone side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Hydromorphone Contraindications / cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- S - Serotonin syndrome (with MAOI, don’t give if MAOI taken within 14 days)
- S - Sphincter of Odds spasm (consider biliary disease or acute pancreatitis)
- H - Histamine Release
- P - Pruritus (itching)
Fentanyl (alternate name)
sublimaze
Fentanyl structure:
Phenylpiperidine
Fentanyl potency
100x more potent than morphine
Fentanyl MOA:
- Mu agonist
- Inhibit (GPCR -Gi) the release of excitatory neurotransmitters Ach, NE, dopamine, glutamate, and substance P (pre-synaptic Ca channel inactivation)
- Increase post-synaptic K conductance (hyperpolarizes)
- Inhibits adenylate cyclase by activating GI proteins and subsequently reduces cAMP, decreasing neuronal excitability
- Upregulation of adenylate cyclase can lead to withdrawal symptoms if drug/inhibition is removed (chronic use)5. Inhibition of adenylate cyclase
Fentanyl Onset:
1-2 min
Fentanyl Duration of action:
30-60 min
Fentanyl PB:
75%
Fentanyl metabolism:
CYP3A4, Renal, bile
Fentanyl IV analgesia dose:
IV: 1-2 mcg/kg - analgesia
Fentanyl IV surgical stimulation dose:
IV 1.5-3 mcg/kg - surgical stimulation
Fentanyl side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Fentanyl contraindications / cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- *S - Serotonin Syndrome (pt on MAOIs, SSRIs, SNRIs, tricyclics, 5-HT3 antagonists?)
- S - Sphincter of Oddi spasm (consider biliary disease or acute pancreatitis)
- S - Skeletal muscle rigidity
- B - Bradycardia
Alfentanil (alternate name)
Alfenta
Alfentanil structure:
phenylpiperidine
Alfentanil potency:
15x more potent than morpine
Alfentanil MOA:
- Mu agonist
- Inhibit the release of excitatory neurotransmitters Ach, NE, dopamine, glutamate, and substance P (pre-synaptic Ca channel inactivation)
- Increase post-synaptic K conductance (hyperpolarizes)
- Inhibits adenylate cyclase by activating GI proteins and subsequently reduces cAMP, decreasing neuronal excitability
- Upregulation of adenylate cyclase can lead to withdrawal symptoms if drug/inhibition is removed (chronic use)
Alfentanil Onset:
1-2 min
Alfentanil duration of action:
30-60 min
Alfentanil PB:
95%
Alfentanil metabolism:
CYP3A4 - excreted by kidneys
Alfentanil IV dose:
IV: 15 mcg/kg
Alfentanil IV for unconscious state dose:
IV: 150-300 mcg/kg (for unconscious state)
Alfentanil side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Alfentanil contraindications / cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- S - 1. Serotonin Syndrome (pt on MAOIs?)
- S - Sphincter of Oddi spasm (consider biliary disease or acute pancreatitis)
- S - Skeletal muscle rigidity
- B - Bradycardia
Remifentanil (alternate name):
Ultiva
Remifentanil structure:
phenylpiperidine
Remifentanil potency:
300x as potent as morphine
Remifentanil MOA:
- Mu agonist
- Inhibit (GPCR -Gi) the release of excitatory neurotransmitters Ach, NE, dopamine, glutamate, and substance P (pre-synaptic Ca channel inactivation)
- Increase post-synaptic K conductance (hyperpolarizes)
- Inhibits adenylate cyclase by activating GI proteins and subsequently reduces cAMP, decreasing neuronal excitability
- Upregulation of adenylate cyclase can lead to withdrawal symptoms if drug/inhibition is removed (chronic use)
Remifentanil onset:
1-2 min
Remifentanil duration of action:
5-10 min
Remifentanil PB:
75%
Remifentanil metabolism:
plasma esterases, Renal
Remifentanil IV push dose:
IV: 0.5-1 mcg/kg (over 60-90 seconds) (Ideal body weight)
Remifentanil IV drip maintenance dose:
IV: 0.05-2 mcg/kg/min (ideal body weight)
Remifentanil side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Remifentanil Contraindications / cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- S - 1. Serotonin Syndrome (pt on MAOIs?)
- S - Sphincter of Oddi spasm (consider biliary disease or acute pancreatitis)
- S - Skeletal muscle rigidity
- B - Bradycardia
Sufentanil (alternate name)
Sufenta
Sufentanil structure:
Phenylpiperidine
Sufentanil potency:
1000x as potent as morphine
Sufentanil MOA:
- Mu agonist
- Inhibit (GPCR -Gi) the release of excitatory neurotransmitters Ach, NE, dopamine, glutamate, and substance P (pre-synaptic Ca channel inactivation)
- Increase post-synaptic K conductance (hyperpolarizes)
- Inhibits adenylate cyclase by activating GI proteins and subsequently reduces cAMP, decreasing neuronal excitability
- Upregulation of adenylate cyclase can lead to withdrawal symptoms if drug/inhibition is removed (chronic use)
Sufentanil onset:
1-2 min
Sufentanil duration of action:
30-60 min
Sufentanil PB:
95%
Sufentanil Metabolism
CYP3A4
Sufentanil IV dose:
IV: 0.1-0.4 mcg/kg
Sufentanil side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Sufentanil contraindications / cautions
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- S - 1. Serotonin Syndrome (pt on MAOIs?)
- S - Sphincter of Oddi spasm (consider biliary disease or acute pancreatitis)
- S - Skeletal muscle rigidity
- B - Bradycardia
Nalbuphine (alternate name)
nubain
Nalbuphine structure:
Opioid related chemically to oxymorphone and naloxone
Nalbuphine MOA:
Kappa agonist
Mu antagonist
Nalbuphine onset:
1-2 min
Nalbuphine duration of action:
4-6 hr
Nalbuphine PB:
50%
Nalbuphine metabolism:
Glucuronidation
Nalbuphine IV dose:
IV: 0.3-3 mg/kg (over 10-15 min)
Nalbuphine IV maintenance dose (weight based):
0.25-0.5 mg/kg PRN
Nalbuphine side effects (same for all narcotics):
- R - Respiratory depression
- A - Allergic reaction possible
- N - Nausea/vomiting
- C - Constipation
- H - Hypotension
Nalbuphine contraindications / cautions:
- M - MAC (synergistically reduces)
- D - Dependence
- B - Beers criteria (caution in older patients)
- S - 1. Serotonin Syndrome (pt on MAOIs?)
- S - Sphincter of Oddi spasm (consider biliary disease or acute pancreatitis)
- S - Skeletal muscle rigidity
- B - Bradycardia
*8. Ceiling effect 30mg